No minimum effective dose or maximum tolerated dose has been established in human oral trials
The goal is to deliver the medication into the fatty layer between your skin and muscle
The dosing schedule, duration, and administration method are determined during your consultation based on your health history, goals, and lab work
BPC157 has shown no toxicity in animal studies, but human safety is uncertain
Mast Cell Activation Syndrome Treatment Conventional treatment for mast cell activation syndrome generally involves the use of pharmaceutical and over-the-counter medications to alleviate symptoms, such as the following medications: Epinephrine (such as an EpiPen) for severe reactions First generation H1 blockers diphenhydramine (Benadryl) and hydroxyzine (Vistaril) Second generation H1 blockers, including loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) H2 blockers, such as ranitidine (Zantac) and famotidine (Pepcid) Aspirin, to block production of prostaglandin D2 and reduce flushing
Key points include: use an alcohol swab on the vial stopper before each draw, inject bacteriostatic water slowly down the side of the vial (never directly onto the powder), and gently swirl rather than shake to dissolve